SCHEMBL4833801

SCHEMBL4833801

CC(C)OC(=O)c1ccccc1OCCN

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.52
LMNA P02545 5/20 0.50
KDM4E B2RXH2 4/20 0.50
ALDH1A1 P00352 3/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
NPC1 O15118 1/20 0.49
MAPT P10636 4/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
KMT2A Q03164 3/20 0.46
MEN1 O00255 2/20 0.46
NR1I2 O75469 1/20 0.46
CHRM2 P08172 1/20 0.46
CYP3A4 P08684 1/20 0.46
ADRA2A P08913 1/20 0.46
OPRK1 P41145 1/20 0.46
HTR2B P41595 1/20 0.46
SLC6A3 Q01959 1/20 0.46
HDAC6 Q9UBN7 1/20 0.46
ADRB2 P07550 1/20 0.44
ADRB1 P08588 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28020528 0.86 ADRB2 (0.57) HTTLMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL28020116 0.85 LMNA (0.57) HTTLMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL7072440 0.83 HSP90AA1 (0.58) HTTLMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL10324240 0.83 HCRTR1 (0.55) HTTLMNAKDM4EALDH1A1NPC1
SCHEMBL28020074 0.81 ALDH1A1 (0.53) HTTLMNAKDM4EALDH1A1SMN1; SMN2
Hydrochloric Acid SCHEMBL6181188 0.81 HSP90AA1 (0.57) HTTLMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL11339323 0.81 KDM4E (0.52) HTTLMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL16093320 0.80 TSHR (0.61) HTTLMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL2135651 0.79 KDM4E (0.61) HTTLMNAKDM4EALDH1A1SMN1; SMN2
SCHEMBL27703396 0.78 PLAU (0.46) LMNAKDM4EALDH1A1NPC1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102746214-A Novel indoline compounds FOURNIER LAB SA 2012-10-24 CN disclosed
US-7465811-B2 Indoline compounds LABORATOIRES FOURNIER S.A. (FR) 2008-12-16 US disclosed
US-20080119465-A1 Novel Indoline Compounds LABORATORIES FOURNIER S.A. (FR) 2008-05-22 US disclosed
CN-101184731-A Indoline compounds FOURNIER LAB SA (FR) 2008-05-21 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119465-A1 Novel Indoline Compounds GPR119, INSR, IRS1 HTT 36/4885LMNA 1943/4885KDM4E 1574/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.